These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7134064)

  • 41. [Cancerous and precancerous changes in the tumor margin areas of patients with bladder cancers].
    Blume B; Theuring F
    Z Urol Nephrol; 1985 Feb; 78(2):71-6. PubMed ID: 3993243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. I. Histological description.
    Carbin BE; Ekman P; Gustafson H; Christensen NJ; Sandstedt B; Silfverswärd C
    J Urol; 1991 May; 145(5):968-71. PubMed ID: 2016811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility.
    Sørensen FB; Sasaki M; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
    Lab Invest; 1994 Feb; 70(2):242-54. PubMed ID: 8139265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear size and chromatin concentration in transitional cell carcinoma of the human urinary bladder.
    Fossa SD; Kaalhus O
    Beitr Pathol; 1976 Apr; 157(2):109-25. PubMed ID: 1275858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Grading in superficial bladder cancer. (1). Morphological criteria.
    Pauwels RP; Schapers RF; Smeets AW; Debruyne FM; Geraedts JP
    Br J Urol; 1988 Feb; 61(2):129-34. PubMed ID: 3349277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative microscopy of human DNA topoisomerase II-alpha expression in transitional cell carcinoma of the bladder.
    Rath-Wolfson L; Hammel I; Kugel V; Leib Z; Dekel Y; Koren R
    Anal Quant Cytol Histol; 2004 Aug; 26(4):181-6. PubMed ID: 15457669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between non-invasive papillary lesions and invasive bladder carcinoma.
    Brawn PN
    Cancer; 1984 Aug; 54(4):620-3. PubMed ID: 6744201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ACP Broadsheet 130: November 1991. Gross examination of bladder specimens.
    Parkinson MC; Fisher C
    J Clin Pathol; 1991 Nov; 44(11):890-5. PubMed ID: 1752977
    [No Abstract]   [Full Text] [Related]  

  • 50. [Computer-based measurements of bladder cancer urothelial cells by high-resolution microscopic-cytophotometric system (author's transl)].
    Aeikens B; Liedtke CE; Haussman G; Knitsch G; Hartmann F
    Urol Int; 1981; 36(5):298-306. PubMed ID: 7324293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of histological malignant stages of epithelial bladder tumours: a simplified classification.
    Cavazzana P
    Eur Urol; 1976; 2(1):13-4. PubMed ID: 971682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe atypia of transitional epithelium and carcinoma of the urinary bladder.
    Cooper PH; Waisman J; Johnston WH; Skinner DG
    Cancer; 1973 May; 31(5):1055-60. PubMed ID: 4705146
    [No Abstract]   [Full Text] [Related]  

  • 53. Proliferative pattern of urothelial bladder cancer and urothelial atypias.
    Helpap B; Schwabe HW; Adolphs HD
    J Cancer Res Clin Oncol; 1985; 109(1):46-54. PubMed ID: 3972885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Large tissue histology in vesical carcinoma.
    King WW; Holleman IL; Cox CE
    South Med J; 1972 Jun; 65(6):711-5. PubMed ID: 4555760
    [No Abstract]   [Full Text] [Related]  

  • 55. The value of nuclear area as a prognostic factor in T1 papillary transitional cell carcinoma of the bladder.
    Portillo JA; Val-Bernal JF; Garijo MF; Buelta L; Gutiérrez JL
    Br J Urol; 1992 Dec; 70(6):622-7. PubMed ID: 1486388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A symposium on controversies in the pathology of transitional cell carcinomas of the urinary bladder, Part II.
    Amin MB; Murphy WM; Reuter VE; Ro JY; Ayala AG; Weiss MA; Eble JN; Young RH
    Anat Pathol; 1997; 2():71-110. PubMed ID: 9575371
    [No Abstract]   [Full Text] [Related]  

  • 57. Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder.
    Lipponen PK; Kosma VM; Collan Y; Kulju T; Kosunen O; Eskelinen M
    Eur Urol; 1990; 17(4):333-7. PubMed ID: 2364975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic significance of morphometry in T1 bladder tumours.
    Ooms EC; Essed E; Veldhuizen RW; Alons CL; Kurver P; Boon ME
    Histopathology; 1981 May; 5(3):311-8. PubMed ID: 7239451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histomorphometry and pattern recognition analysis of urothelial papillary lesions.
    Montironi R; Scarpelli M; Pisani E; Ansuini G; Mariuzzi GM
    Tumori; 1984 Oct; 70(5):463-6. PubMed ID: 6506232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Non-condensed" and "condensed" chromain in transitional cell carcinoma of the human urinary bladder.
    Fosså SD; Kaalhus O
    Beitr Pathol; 1976 Aug; 158(3):241-54. PubMed ID: 971257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.